Clinical Trials Logo

Preeclampsia Mild clinical trials

View clinical trials related to Preeclampsia Mild.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03815110 Completed - Clinical trials for Gestational Hypertension

Preeclampsia Risk Assessment: Evaluation of Cut-offs to Improve Stratification

PRAECIS
Start date: December 20, 2018
Phase:
Study type: Observational

The purpose of this study is to 1. Identify a cut-off for the ratio of the serum proteins soluble FMS-like Tyrosine Kinase 1 (sFLT-1) and placental growth factor (PlGF) that identifies women will who develop preeclampsia with severe features within 2 weeks of testing (clinically positive) from those who do not develop preeclampsia with severe features within 2 weeks of testing (clinically negative) among preterm pregnant women with hypertensive disorders of pregnancy. And 2. To validate the cut-off the ratio of sFLT-1 and PlGF and to validate the performance of the automated assays used to find the cut-off. Test performance includes positive predictive value, negative predictive value, sensitivity, and specificity. Subjects will provide blood, urine, and saliva samples at the time of enrollment. Samples will be frozen for batch assessment of sFLT-1 and PlGF levels by automated assays. Clinicians, subjects, and researchers will be blinded to protein level assessment, therefore assay results will not affect clinical management.